PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), FLOW CYTOMETRY (In Karad)

Overview

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, life-threatening blood disorder caused by a deficiency of certain protective proteins on blood cells. This makes the cells highly susceptible to destruction by the immune system. PNH Flow Cytometry is considered the gold-standard method for detecting PNH clones because it offers exceptional accuracy, sensitivity, and speed.

Using flow cytometry, FACS analysis, and flow cytometry antibodies, the test identifies GPI-anchored proteins such as CD55 and CD59 on blood cells. Any deficiency or absence of these proteins indicates the presence of PNH clones. This technique is far superior to conventional tests because it can detect even very small clones (<1%), making it crucial for early diagnosis and treatment.

Why PNH Flow Cytometry is Important

PNH can cause severe complications including chronic hemolysis, blood clots, kidney damage, and life-threatening infections. Early identification of clone size and monitoring over time is essential for managing these risks.

The PNH Flow Cytometry Test is important for several reasons:

1. Gold-standard diagnostic tool for PNH detection

2. High-sensitivity detection with flow cytometry analysis

3. Identifies deficiency of CD55, CD59, and other GPI-linked markers

4. Helps differentiate PNH from other hemolytic anemias

5. Essential in evaluating patients with aplastic anemia, myelodysplastic syndromes, or unexplained hemolysis

6. Supports treatment decisions and response monitoring for drugs like eculizumab and ravulizumab

Because PNH may progress silently, regular monitoring through flow cytometry ensures timely medical intervention.

How PNH Flow Cytometry Testing is Done

The testing procedure is simple, minimally invasive, and highly accurate. Flow cytometry allows thousands of cells to be analyzed within seconds using fluorescent markers and FACS cytometry technology.

Steps Involved:

1. Sample Collection: A small blood sample is collected in an EDTA tube.

2. Lab Processing: The sample is stained with specific flow cytometry antibodies targeting CD55, CD59, and other GPI-anchored proteins.

3. Flow Cytometry Analysis: Using FACS flow cytometry, the instrument passes laser light through each cell, evaluating the presence or absence of protective proteins.

4. Interpretation: The percentage of PNH clones in RBCs, neutrophils, and monocytes is calculated.

5. Reporting: Clone size, pattern, and clinical correlation are provided.

Parameters Measured

1. CD55 and CD59 expression on RBCs

2. FLAER binding on granulocytes & monocytes

3. RBC PNH clone percentage

4. WBC PNH clone percentage

5. Type II and Type III clone classification

6. Overall PNH clone expansion or reduction

Benefits of PNH Flow Cytometry Testing

The PNH Flow Cytometry Test offers remarkable advantages:

1. Highly Accurate: Precision diagnosis using advanced cytometry

2. Highly Sensitive: Detects even very small PNH populations

3. Reliable Monitoring: Helps track clone size over time

4. Supports Clinical Decisions: Guides therapy initiation or modification

5. Fast Turnaround: Rapid and dependable reporting

6. Non-invasive: Only a routine blood sample required

This makes flow cytometry, facs analysis, and pnh flow cytometry the most preferred method for hematologists worldwide.

Why Choose Diagnopein for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), FLOW CYTOMETRY Test?

1. Modern laboratory equipped with advanced flow cytometry instruments

2. Expert hematopathologists and cytometry specialists

3. High-sensitivity FACS cytometry for accurate clone detection

4. Standardized protocols ensuring reliability and precision

5. Quick turnaround time with comprehensive reporting

6. Affordable diagnostic cost with trusted quality

Diagnopein ensures accurate detection and monitoring, supporting better clinical outcomes for patients with PNH and related disorders.